Drugs / BMS-686117
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00508287 | Aug → Nov 2007 | type 2 diabetes mellitus | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMS-686117 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00508287 ↗ |
| Modality | Protein / enzyme biologic | — CHEMBL4802140 ↗ |
| Route | Subcutaneous | “Subcutaneous” NCT00508287 ↗ |